期刊文献+

癌基因Stat3与结直肠癌临床病理特征的关系 被引量:9

Expression of a oncogene signal transducer and activator of transcription 3 (Stat3) and its relation to clinicopathological features of colorectal cancer
原文传递
导出
摘要 目的探讨转录信号传导子与激活子 3(Stat3)在结直肠癌中的表达情况 ,分析Stat3的表达与结直肠癌临床病理特征的关系。方法应用Westernblot检测 4 5例结直肠癌组织及其邻近正常肠粘膜中Stat3蛋白的表达。结果结直肠癌组织中Stat3蛋白表达水平明显高于正常肠粘膜(P <0 0 5 ) ,平均为正常肠粘膜的 2 4 5倍 ;Stat3表达水平与Dukes分期、分化及淋巴结转移有关 (P <0 0 5 ) ;Stat3表达水平与肿瘤大小、远处转移、年龄、性别以及是否浸润浆膜无关 (P >0 0 5 )。结论Stat3的过量表达可能在结直肠癌的发生、发展过程中起重要作用。 Objective To investigate the expression of a novel oncogene Stat3 in colorectal cancer. Methods Western blot analysis was performed on cancerous and normal colonic tissue of 45 patients with colorectal carcinoma. ResultsStat3 protein level increased in colorectal cancer compared with adjacent normal mucosa ( P <0 05), the median value was in 2 45 fold increase, it was found that overexpression of Stat3 was related to Dukes stage, differentiation and lymph node metastasis in colorectal cancer ( P <0 05). No significant differences were found between Stat3 expression and such factors as tumor size, serosa invasion and distant metastasis. Conclusions Taken together, overexpression of Stat3 may play an important role in colorectal tumorigenesis and disease progression.
出处 《中华普通外科杂志》 CSCD 北大核心 2002年第7期401-403,共3页 Chinese Journal of General Surgery
基金 中华医学会CMB基金 (ORF980 7) 教育部留学回国启动基金 (F43 8)
关键词 结肠直肠肿瘤 信号传递 转录因子 病理 Colorectal neoplasms Signal transduction Transcription factors
  • 相关文献

参考文献2

  • 1Shan Wang M.D., Ph.D.,B. Mark Evers M.D.. Caco-2 cell differentiation is associated with a decrease in stat protein levels and binding[J] 1999,Journal of Gastrointestinal Surgery(2):200~207
  • 2Shan Wang MD, PhD,Stephen K. Tyring MD, PhD,Courtney M. Townsend MD,B. Mark Evers MD. Interferon-mediated activation of the STAT signaling pathway in a human carcinoid tumor[J] 1998,Annals of Surgical Oncology(7):642~649

同被引文献61

  • 1龚龙波,罗学来,刘双又,陶德定,龚建平,胡俊波.GRIM-19及其靶基因产物STAT3与结直肠癌恶性程度的关系[J].癌症,2007,26(7):683-687. 被引量:43
  • 2Weinberg RA.Oncogenes and tumor suppressor genes. CA Cancer J Clin, 1994,44 : 160-170.
  • 3Hughes RM. Strategies for cancer gene therapy. J Surg Oncol, 2004 , 85:28-35.
  • 4Huang G,Lu H,Hao A,et al. GRIM-19,a cell death regulatory protein,is essential for assembly and function of mitochondrial complex Ⅰ. Mol Cell Biol,2004 ,24 :8447-8456.
  • 5Angell JE, Lindner D J, Shapiro PS, et al. Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-beta and retinoic acid combination, using a genetic approach. J Biol Chem, 2000,275:33416-33426.
  • 6Chidambaram NV, Angell JE, Ling W, et al. Chromosomal localization of human GRIM-19, a novel IFN-beta and retinoic acid-activated regulator of cell death. J Interferon Cytokine Res,2000,20:661-665.
  • 7Zhang X, Choe MS,Lee JE, et al. ASCO Meeting Abstracts,2005,23 : 5519.
  • 8Levy DE, Darnell JE. STATs: transcriptional control and biological impact. Nat Rev Mol Cell Biol, 2002, 3:651-662.
  • 9Bromberg JF, Wrzeszczynska MH, Devan G, et al. STAT3 as an oncogene. Cell, 1999, 98:295-303.
  • 10Wang S, Evers BM. Caco-2 cell differentiation is aasociated with a decrease in stat protein levels and binding. J Gastrointest Surg, 1999, 3:200-207.

引证文献9

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部